Related Experiment Video
Updated: Feb 3, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Roles of Tristetraprolin in Tumorigenesis
Jeong-Min Park1, Tae-Hee Lee2, Tae-Hong Kang3
1Department of Biological Science, Dong-A University, Busan 49315, Korea. zmpark@donga.ac.kr.
Abstract:
Genetic loss or mutations in tumor suppressor genes promote tumorigenesis. The prospective tumor suppressor tristetraprolin (TTP) has been shown to negatively regulate tumorigenesis through destabilizing the messenger RNAs of critical genes implicated in both tumor onset and tumor progression. Regulation of TTP has therefore emerged as an important issue in tumorigenesis. Similar to other tumor suppressors, TTP expression is frequently downregualted in various human cancers, and its low expression is correlated with poor prognosis. Additionally, disruption in the regulation of TTP by various mechanisms results in the inactivation of TTP protein or altered TTP expression. A recent study showing alleviation of Myc-driven lymphomagenesis by the forced expression of TTP has shed light on new therapeutic avenues for cancer prevention and treatment through the restoration of TTP expression. In this review, we summarize key oncogenes subjected to the TTP-mediated mRNA degradation, and discuss how dysregulation of TTP can contribute to tumorigenesis. In addition, the control mechanism underlying TTP expression at the posttranscriptional and posttranslational levels will be discussed.
Insights
Tristetraprolin (TTP) suppresses tumors by degrading oncogene messenger RNAs. Restoring TTP expression offers a promising therapeutic strategy for cancer prevention and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumor suppressor genes are critical in preventing cancer development.
- Tristetraprolin (TTP) acts as a prospective tumor suppressor by destabilizing oncogenic messenger RNAs.
- Downregulation of TTP is observed in many human cancers, correlating with poor prognosis.
Purpose of the Study:
- To review key oncogenes regulated by TTP-mediated mRNA degradation.
- To discuss the contribution of TTP dysregulation to tumorigenesis.
- To explore TTP expression control mechanisms at posttranscriptional and posttranslational levels.
Main Methods:
- Literature review of studies on TTP function in tumorigenesis.
- Analysis of TTP's role in destabilizing oncogene mRNAs.
- Examination of TTP regulation at posttranscriptional and posttranslational levels.
Main Results:
- TTP destabilizes mRNAs of genes involved in tumor onset and progression.
- Dysregulation of TTP contributes to cancer development.
- Restoring TTP expression can alleviate Myc-driven lymphomagenesis.
Conclusions:
- TTP is a crucial tumor suppressor whose dysregulation promotes cancer.
- Understanding TTP's regulatory mechanisms is vital for developing novel cancer therapies.
- Restoring TTP function presents a potential therapeutic avenue for cancer treatment.
Related Concept Videos
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Role-Based Identity
Role of Hippocampus in Memory
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Role of Amygdala in Memory
One of the...

